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AbstrAct
Objective To investigate the effect of whole-body 
vibration exercise (WBV) on fracture risk in adults ≥50 
years of age.
Design A systematic review and meta-analysis 
calculating relative risk ratios, fall rate ratio and absolute 
weighted mean difference using random effects models. 
Heterogeneity was estimated using I2 statistics, and the 
Cochrane Collaboration’s risk of bias tool and the GRADE 
approach were used to evaluate quality of evidence and 
summarise conclusions.
Data sources The databases PubMed, Embase and the 
Cochrane Central Register from inception to April 2016 and 
reference lists of retrieved publications.
Eligibility criteria for selecting studies Randomised 
controlled trials examining the effect of WBV on fracture 
risk in adults ≥50 years of age. The primary outcomes 
were fractures, fall rates and the proportion of participants 
who fell. Secondary outcomes were bone mineral density 
(BMD), bone microarchitecture, bone turnover markers and 
calcaneal broadband attenuation (BUA).
results 15 papers (14 trials) met the inclusion criteria. 
Only one study had fracture data reporting a non-
significant fracture reduction (risk ratio (RR)=0.47, 95% CI 
0.14 to 1.57, P=0.22) (moderate quality of evidence). Four 
studies (n=746) showed that WBV reduced the rate of falls 
with a rate ratio of 0.67 (95% CI 0.50 to 0.89, P=0.0006; 
I2=19%) (moderate quality of evidence). Furthermore, data 
from three studies (n=805) found a trend towards falls 
reduction (RR=0.76, 95% CI 0.48 to 1.20, P=0.24; I2=24%) 
(low quality of evidence). Finally, moderate to low quality 
of evidence showed no overall effect on BMD and only 
sparse data were available regarding microarchitecture 
parameters, bone turnover markers and BUA.
conclusions WBV reduces fall rate but seems to have 
no overall effect on BMD or microarchitecture. The impact 
of WBV on fractures requires further larger adequately 
powered studies. This meta-analysis suggests that WBV 
may prevent fractures by reducing falls.
PrOsPErO registration number CRD42016036320; 
Pre-results.
IntrODuctIOn 
Fragility fractures are associated with much 
morbidity, mortality and cost to society.1 2 
In Europe, the direct medical cost of these 
fractures has been estimated at €31.7 billion 
per year, expected to rise to €76.7 billion by 
2050.3 Propensity to fall and osteoporosis 
are the major determinants of fragility frac-
tures.1 4 5 
One-third of the population over 65 years of 
age falls at least once a year.6 Increasing age, 
frailty, comorbidity, reduced muscle strength 
and impaired balance contribute to the risk 
of falls.4 6 In Europe, 22 million women and 
5.5 million men were estimated to have oste-
oporosis in 2010.1 WHO criteria for diag-
nosing osteoporosis is based on measurement 
of bone mineral density (BMD), but there 
are also other important aspects of bone 
fragility including microarchitecture and 
bone turnover.7 8 The combination of age-re-
lated bone loss and an increased risk of falls 
cause a higher incidence of fragility fractures 
in people aged 50 years or more.1 9 With an 
ageing population, the increased cost caused 
by fragility fractures poses a significant chal-
lenge to healthcare systems.1 3 Reducing frac-
ture risk with the dual approach of lowering 
fall risk and enhancing bone strength is 
therefore desirable.10
Whole-body vibration exercise (WBV) 
has been proposed as an exercise modality 
anabolic to bone, capable of enhancing 
balance and improving muscle strength.11–14 
Animal studies have showed that mechanical 
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Research
strengths and limitations of this study
 ► This is the first systematic review comprehensively 
conducting a meta-analysis on the effect of whole-
body vibration exercise (WBV) on the overall risk of 
fractures, including falls.
 ► An extensive systematic literature search identified 
all available randomised controlled trials using 
WBV in adults aged 50 on falls, fractures and bone 
parameters.
 ► A risk of selection bias exists due to no inclusion 
of non-English language literature, grey literature or 
adverse effects.
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signals introduced via vibration stimulate bone forma-
tion and suppress bone resorption.15–17 The accelerations 
from vibration platforms are transmitted to the person 
standing on the plate from the feet to the adjacent 
muscles and bones. When the plate moves the adjacent 
muscles provide contractions as a reflex to the stimulus.18 
WBV has been proposed to counteract ageing’s suppres-
sion on osteoblast activity thereby preventing bone loss.15 
WBV with high magnitude (high frequency and/or 
amplitude) has shown to increase muscular activation, 
and this technique has been suggested as an alternative to 
weight-bearing exercise.18 WBV training protocols varies 
from a few minutes vibration up to 20 min depending on 
the peak acceleration.
The vibration plates can be assessed at home, in the 
local community or at rehabilitation units with different 
forms of monitoring and supervision. The WBV is used as 
an intervention aimed at preventing bone loss, enhancing 
muscle strength and balance.
Several studies have investigated the role of WBV on 
BMD, muscle strength and balance.11 12 14 19–24 However, 
the results have been inconsistent perhaps due to differ-
ences in types of vibration studied: intervention designs, 
populations assessed and study quality. Fewer studies have 
focused on the effect of WBV on falls and bone strength 
parameters other than BMD.19 20 25–27
Previous systematic reviews on the effect of WBV on 
balance and muscle strength in older adults have reported 
improvement in lower extremity muscle strength or in 
certain balance measures.28–32 Systematic reviews focusing 
on BMD have shown inconsistent results,32–35 with some 
showing no overall effect,32 others a small increase in 
BMD of the hip33 or no effect on the hip but an effect 
on lumbar spine,35 while some found a BMD increase in 
certain subgroups only.34 To the best of our knowledge, 
no systematic review has comprehensively investigated 
the role of WBV on fragility fractures and overall risk of 
fragility fractures, including falls and bone quality.
The objectives of this systematic review were to address 
if WBV in adults over 50 years of age could affect the inci-
dence of fractures, falls, as well as estimates of bone mass, 
architecture and turnover.
MEthODs
Data sources and searches
Literature searches were conducted in the following elec-
tronic bibliographic databases: PubMed, Embase and 
The Cochrane Library (Cochrane Central Register of 
Controlled Trials). The searches were conducted from 
inception to 4 April 2016. Additionally, we performed 
manual searches of the reference lists of retrieved publi-
cations and earlier reviews.29 32–35 An updated search was 
conducted by end of January 2017 to check for any new 
relevant studies prior to submission.
The search string was structured with librarian assis-
tance using the PICO method: P (population)=adults 
≥50 years of age, I (intervention)=whole-body sinusoidal 
vibration (ie, constant vibration frequency) from a plat-
form, C (comparison)=no intervention, sham, normal 
care or same exercise in both arms and O (outcome)=-
fractures, falls and bone property parameters.
The searches were conducted without filters or restric-
tions, and the search string is available in online supple-
mentary appendix 1.
study selection
One author (DBJ) screened title and abstracts. Two 
authors (DBJ, KT) independently evaluated the full-text 
papers and eligibility. Conflicts were resolved by a third 
author (JR). The selection was conducted using the soft-
ware Covidence (Covidence systematic review software; 
Veritas Health Innovation, Melbourne, Australia) and a 
standardised eligibility form.
Inclusion criteria: randomised controlled trials (RCTs) 
investigating the effect of WBV on fractures, falls and 
bone properties within the population ≥50 years of 
age. WBV had to be whole-body sinusoidal vibration 
(ie, constant vibration frequency) from a platform that 
vibrates vertically or side alternating, with no restriction 
on frequency, amplitude or magnitude. The participants 
had to stand during the WBV. The control groups had to 
have either no intervention, usual care, sham vibration, 
activity unlikely to influence bone or fall risk parameters 
or exercise or interventions identical in both arms (where 
WBV was an add-on in one group).
Trials were ineligible if non-RCT, animal studies, popu-
lation age <50 years given by the mean age minus two 
times the SD or if the participants were younger than 50 
years of age, non-English language publications, posters 
or conference abstracts and if vibration was applied 
locally, by electrical current, non-standing, with random 
frequencies, using vibrating insoles or by ultrasound.
Data extraction and quality assessment
Data were independently extracted by two authors (DBJ, 
KT), using a standardised data extraction form. For all 
included studies, information was gathered on country of 
origin, design, randomisation, population, intervention, 
adherence, analyses per intention to treat or per protocol 
and results.
Primary outcomes of interest were fractures and 
falls, and secondary outcomes were bone parameters 
including BMD (spine and hip), bone microarchitec-
ture (assessed by high-resolution peripheral quantita-
tive CT (HRpQCT) or bone biopsy), bone turnover 
markers (carboxy-terminal collagen cross-link (CTX) 
(bone resorption) or amino terminal propeptide of type 
I collagen (P1NP) (bone formation)) or calcaneal quan-
titative ultrasound (BUA).
Data were extracted from the intervention and control 
groups, and if the WBV was an add-on to exercise, then 
the exercise and WBV arm was compared with the exer-
cise arm.
The numbers of fractures and the participants contrib-
uting with data were extracted in the groups.
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Figure 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram presenting the 
literature searches and the included studies.
Regarding falls, the number of falls, the number of 
participants who experienced falls and the number 
of participants contributing with data and length of 
follow-up were extracted. To reduce the clinical hetero-
geneity, only falls data from the intervention periods of 
the studies were extracted.
For BMD, bone turnover markers, microarchitecture 
parameters and BUA, the absolute mean difference (with 
SDs) from baseline to follow-up were extracted in the 
intervention and control groups.
If the data were reported different than stated above, 
the corresponding authors of the included studies were 
contacted to acquire the data.
The risk of bias for each included study was assessed 
using the Cochrane ‘Risk of bias tool’.36 The performance 
biases were divided in patient reported outcomes (falls) 
and bone property parameters. The quality of evidence 
was assessed for each outcome using the five GRADE 
considerations, and summaries of findings were created 
using the GRADE guidelines.37
strategy for data synthesis and analysis
The results across studies were pooled by numbers of 
events calculating relative risk of fractures and for expe-
riencing one or more falls (fallers) with 95% CI. Fall 
incident rate ratio per patient year with 95% CI was calcu-
lated using the reported rate of falls (falls per person-
year), or the rate of falls in each group were calculated 
from the total number of falls and the total length of 
the intervention duration (person-years) for participants 
contributing with data in each group using STATA V.14. 
The mean differences in BMD, bone turnover markers, 
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microarchitecture parameters and BUA were pooled 
calculating the absolute mean difference and 95% CI. The 
mean differences were calculated subtracting the base-
line means from the follow-up or by multiplying percent 
change with baseline means. The SDs were calculated 
using the formula: ((HCI-LCI/2/TINV(0.05;n-1)*√ (n)), 
where HCI is the highest value of 95% CI, LCI the lowest 
value of 95% CI and n the sample size of the group, 
TINV (0.05;n-1)=t value for a 95% CI from a sample size 
of n,36 by using P values for change over time in Review 
Manager calculator (RevMan) V.5.3 (Copenhagen: The 
Nordic Cochrane Centre, The Cochrane Collaboration 
2014) or by the formula SD=((mi–mc)/TINV(P value; 
df))/√ (1/ni+1/nc), where mi is the mean difference in 
the intervention group, mc is the mean difference in the 
control group, df is degrees of freedom, ni is the sample 
size in the intervention group and nc is the sample size 
in the control group.36 When cluster randomisation was 
used, adjustments were applied.36 The number of partic-
ipants contributing with data in each group was used 
for the calculations if this was reported; otherwise, the 
number of participants randomised to each group was 
extracted. Where possible, the longest follow-up times 
were used (with 2 papers reporting 3-month and 6-month 
data, 6-month data were used).26 27 In case of post hoc 
study extension, the originally planned duration was 
used.22 Calculations were performed using Excel and 
STATA V.14. To allow for variability among the partici-
pants and interventions, the random effect meta-analysis 
model in RevMan was used. Heterogeneity was assessed 
by forest plots and the I2 statistics. Preassigned subgroup 
analyses for sinusoidal vertical and side-alternating WBV 
were done where possible.
The review protocol was registered 1 April 2016 in 
Prospective Register of Systematic Reviews (PROSPERO) 
and reported according to the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) 2009 
statement, and the checklist was completed.38
rEsults
study selection and characteristics
A total of 3207 titles and abstracts were initially identi-
fied, and after removal of 959 duplicates, 2248 titles and 
abstracts were screened for relevance. The majority of 
identified papers were excluded because they described 
animal studies, were not RCTs or did not meet the defi-
nition of the intervention. A total of 107 full-text papers 
were read and matched to the inclusion and exclusion 
criteria. Selection of the included studies is illustrated in 
the PRISMA flow diagram (figure 1). The updated search 
revealed no new relevant studies.
study characteristics
A total of 15 papers (14 studies) met the criteria for the 
qualitative synthesis and are described in table 1. The 
studies were published from 2004 to 2015, with an accu-
mulated population of 1839 (ranging from 4220 to 71021 
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Figure 2 The risk of bias assessment.
Figure 3 Effect of WBV on the relative risk of experiencing a fracture. WBV, whole-body vibration.
participants in the included studies). The mean age 
of the overall population was 74 years, with 82% living 
independently and 90% being women. All studies were 
RCT with one trial using cluster randomisation.21 The 
six studies compared WBV with continued daily activi-
ties,20 21 26 39–41 with one study using two different forms 
of WBV.39 Three studies compared WBV with exercise 
or wellness therapy,24 25 42 and one study compared 
WBV with exercise and to continued daily activities.12 
Two studies compared WBV with sham.19 22 One study 
compared WBV and high or low-dose vitamin D supple-
mentation with no training and high or low-dose vitamin 
D supplementation.43 One study compared WBV and 
alendronate with no training and alendronate.23 Eight 
trials reported supervised training,19 20 25 26 39–41 43 two 
electronically monitored,21 22 two using attendance 
logs24 42 and two did not state any form of measurement 
of adherence.12 23
The studies varied in the intervention protocols with 
differences in vibration design, duration and follow-up 
(table 2). Eleven studies used high-magnitude WBV 
(HWBV) (≥1 g in peak acceleration)12 19 20 23–26 40–43 with 
two of these studies comparing vertical with side-al-
ternating vibration and wellness therapy/sham vibra-
tion.19 24 Two studies used low-magnitude WBV (LWBV) 
(<1 g in peak acceleration),21 22 and one study compared 
LWBV to high-magnitude side-alternating WBV.39 In the 
studies, using HWBV, five studies used side-alternating 
vibration19 20 23 24 39 and nine studies used vertical vibra-
tion.12 19 24 25 39–43 Frequencies ranged from 12.5 to 40 Hz, 
peak-to-peak displacement ranged from 0.7 to 4.2 mm and 
peak acceleration from 0.3 to 8 g. The exercises were most 
often vibration spouts lasting from 15 s to 20 min, from 
every day to once a week, and the duration of the inter-
vention were from 6 weeks to 24 months. In 2 studies, the 
participants used flat-soled shoes/gymnastic shoes,12 24 2 
studies described the intervention shoeless,19 26 while the 
other 10 studies did not report a protocol for footwear 
(table 2).
Outcomes
One study reported fractures as the primary outcome. A 
total of six studies reported fall data. Three authors were 
contacted to obtain data on fall rate23 25 and fall risk,42 
and this way data were obtained from one trial.25
Data on bone parameters were reported in per cent 
change or preintervention and postintervention measure-
ments in eight studies. The corresponding authors were 
contacted,12 19–23 39 41 43 and data were obtained this way 
from three studies.19 21 22
In two studies, data were extracted from previous 
reviews,33 34 which reported to have primary data avail-
able from the authors,12 23 41 and in the rest of the studies, 
the outcomes were calculated as described in the method 
section.
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Figure 4 Forest plot of the effect of WBV. (A) The rate ratio of the fall rate/person-years between the WBV and control 
group. (B) The RR of experiencing one or more falls. Area of each square is proportional to study weight in meta-analysis and 
horizontal lines represent exact 95% CIs. Diamonds represent pooled effect estimates from random effects meta-analysis. RR, 
risk ratio; WBV, whole-body vibration.
risk of biases within studies
The majority of studies were categorised as having a low 
risk of bias in the randomisation with unclear risk of bias 
in the allocation due to insufficient reporting in half of 
the studies. The performance bias was categorised as 
high risk when the participants reported falls and were 
not blinded to the intervention. One study used wellness 
therapy in the control group and did not inform the 
participants of the hypotheses and was thus considered 
unclear in the risk of performance bias with respect to 
falls reporting.42 Non-blinding of participants were cate-
gorised as unclear risk of bias when the outcome were 
bone parameters. The risk of bias in selective reporting 
was categorised as low risk if the trial reported all stated 
outcomes in the papers and was conducted before 2005. 
After 2005, trials had to be registered online at a registry 
or having published a study protocol reporting the 
prespecified outcomes. Figure 2 shows a summary of the 
risk of bias assessment.
Fractures
One study reported fractures as a primary outcome (risk 
ratio (RR) 0.48 (95% CI 0.14 to 1.56), with an intracluster 
correlation coefficient of 0.000 (figure 3).
Falls
Four studies reported falls as primary outcome.21 25 26 42 
Three studies reported fallers and the number of falls in 
total in each group during the intervention,21 25 26 and 
one study reported the mean number of falls per partici-
pants.42 One study reported no events in the control arm 
in the 6-week intervention and adjusted rate ratio could 
not be calculated. Pooling the studies with falls reported 
as outcomes showed a fall rate ratio of 0.67 (95% CI 0.50 
to 0.89, P=0.006, I2=19%) (figure 4A) in the intervention 
groups compared with non-intervention and a relative 
risk of experiencing falls of 0.76 (95% CI 0.48 to 1.20, 
P=0.24, I2=24%) (figure 4B).
Two trials reported falls as adverse effects.23 39 A post 
hoc sensitivity analysis was conducted to assess if the inclu-
sion of these trials would alter the result. In this analysis, 
a fall rate/person-years rate ratio of 0.65 (95% CI 0.50 
to 0.85, P=0.002, I2=8%) was found and a relative risk of 
experiencing falls of 0.67 (95% CI 0.46 to 0.98, P=0.04, 
I2=13%) (see online supplementary figure 1a,b).
Post hoc subgroup analyses were conducted to assess 
the association between the duration and the magnitude 
of the vibration and falls, duration over 6 months fall rate 
ratio of 0.61 (95% CI 0.47 to 0.80, P=0.0004, I2=0%, two 
studies), duration over 6 months and relative risk of expe-
riencing falls of 0.65 (95% CI 0.48 to 0.88, P=0.005, I2=0%, 
one study), low-magnitude vibration fall rate ratio of 0.56 
(95% CI 0.40 to 0.78, P=0.0006, one study), high-magni-
tude vibration fall rate ratio of 0.80 (95% CI 0.55 to 1.18, 
P=0.26, I2=0%, two studies) (see online supplementary 
figure 2a–c).
bone mineral density
Seven studies reported data on lumbar spine 
BMD.12 21 23 24 39 40 42 The results showed no overall effect 
with a mean difference of 0.00 (95% CI −0.00 to –0.01, 
P=0.11, I2=22%) (figure 5A). Six studies reported data 
on total hip BMD,12 21 40–43 showing similar results with a 
mean difference of 0.00 (95% CI −0.00 to 0.01, P=0.27, 
I2=50%) (figure 5B). Subgroup analyses with vertical and 
side-alternation vibration explained 44.5% of the hetero-
geneity in the lumbar spine BMD, and side-alternation 
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Figure 5 The effect of WBV exercise in forest plots on (A) areal BMD of the lumbar spine with weighted mean difference and 
95% CI, divided in subgroups with vertical vibration and side-alternating vibration, (B) areal BMD in total hip with weighted 
mean difference and 95% CI, (C) volumetric BMD of the distal tibia with weighted mean difference with 95% CI and (D) WBVs 
effect on volumetric BMD of the distal radius with weighted mean difference and 95% CI. Area of each square is proportional to 
study weight in meta-analysis and horizontal lines represent exact 95% CI. Diamonds represent pooled effect estimates from 
random effects meta-analysis. BMD, bone mineral density; WBV, whole-body vibration.
vibration showed a mean difference of 0.01 (95% CI 0.00 
to 0.02, P=0.04, I2=0%) with 117 participants. All studies 
reporting BMD in total hip used vertical vibration.
One study reported change in total proximal femoral 
trabecular BMD and change in integral lumbar spine 
vertebral BMD.22 The results from the originally planned 
duration of 24 months showed no effect on integral 
lumbar spine vertebral BMD with a mean difference of 
0.00 (95% CI −0.00 to 0.00) and total femoral trabecular 
BMD mean difference of 0.00 (95% CI −0.00 to 0.01) 
(see online supplementary figure 3a,b). Two studies 
reported volumetric BMD (vBMD) of radius and tibia 
using HRpQCT20 or quantitative CT (pQCT) scans.37 
The results for the ultradistal site using HRpQCT and a 
4% site in tibia and radius using pQCT were combined 
in forest plots showing no statistically significant effects 
with a vBMD tibia mean difference of −0.68 (95% CI 
−2.29 to 0.93, P=0.41, I2=0) and a vBMD radius mean 
difference of 1.87 (95% CI −0.62 to 4.36, P=0.30, I2=8%) 
(figure 5C,D).
bone microarchitecture
One study reported measurements of cortical porosity 
(Ct.Po) and trabecular BMD (tbBMD)20 using HRpQCT. 
We refrained from performing a meta-analysis due to the 
limited data (see online supplementary figure 4). In tibia, 
WBV compared with control showed an increase in mean 
difference in Ct.Po of 0.20% (95% CI −0.25 to 0.65) and 
decrease in tbBMD mean difference −0.3 mg HA/cm3 
(95% CI −0.58 to 0.02). In radius, WBV compared with 
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Figure 6 Presents the effect of WBV exercise on bone resorption markers in forest plot with CTX and the reported effect 
on bone formation marker amino terminal P1NP. Area of each square is proportional to study weight in meta-analysis 
and horizontal lines represent exact 95% CIs. Diamonds represent pooled effect estimates from random effects meta-
analysis. CTX, carboxy-terminal collagen cross-link; P1NP, propeptide of type I collagen; WBV, whole-body vibration.
no intervention showed an increase mean difference 
in Ct.Po of 0.10% (95% CI −0.15 to 0.35) and decrease 
in tbBMD mean difference −0.90 mg HA/cm3 (95% CI 
−0.90 to 2.10) (see online supplementary figure 4).
bone turnover markers
One study reported data on the bone resorption marker 
CTX12 and two studies on both CTX and the bone forma-
tion marker P1NP.19 22 One of the studies reported log 
transformed CTX and P1NP19 and no untransformed 
data could be obtained from the authors. The result 
for the meta-analysis on CTX was a mean difference of 
0.01 ng/mL (95% CI −0.06 to 0.08, P=0.73, I2=0) and with 
data available from only one trial, the result for P1NP was 
a mean difference of 4.92 ng/mL (95% CI −3.06 to 12.90) 
(figure 6A,B).
calcaneal buA
A single study reported calcaneal BUA mean change in 
comparing two vibration groups with a control group,39 
we refrained from performing a meta-analysis due to 
the limited data (see online supplementary figure 5). 
The low magnitude vertical vibration group had a mean 
difference of 1.99 dB/MHz (95% CI −0.84 to 4.82) and 
the high-magnitude side-altering vibration group a mean 
change of 4.69 dB/MHz (95% CI 1.61 to 7.77) compared 
with the controls (see online supplementary figure 5).
Quality assessment
Quality of evidence was assessed for each outcome 
(table 3). For the outcome of fractures, the evidence was 
downgraded for imprecision due to the 95% CI around 
the pooled estimate of effect includes both the possi-
bility of no effect and appreciable benefit. The evidence 
for falls rate was downgraded for study limitations due 
to non-blinding of the participants. The risk of falls was 
downgraded for imprecision and study limitations due to 
non-blinding of the participants. Bone parameters were 
all downgraded for indirectness since they are surrogate 
markers for bone strength. Regarding bone parameters, 
the outcomes were downgraded for imprecision if the 
95% CI around the pooled estimate of effect includes 
both the possibility of no effect and appreciable benefit 
and for inconsistency if the I2 statistics showed substantial 
heterogeneity. Publication bias could not be assessed by a 
funnel plot with Egger’s test since all of the meta-analyses 
contained less than 10 studies.36
DIscussIOn
This systematic review and meta-analysis provides 
evidence that WBV exercise reduces fall rate in adults 
above 50 years of age. We found a tendency in reduction 
of the proportion of fallers, no overall effect on BMD, 
whereas only sparse data were available regarding bone 
microarchitecture parameters, bone turnover markers 
and BUA. One study reported fractures showing non-sig-
nificant fracture reduction.
strengths and limitations
This study had some limitations. By not including non- 
English language literature and not extracting data from 
grey literature or adverse effects, the risk of selection bias 
exists. Looking at the studies reporting falls as adverse 
effects in the included studies, the WBV reduces the falls 
rate and risk in agreement with our findings.
Only one study had fractures as primary outcome and 
had a low fracture rate.21 The studies contributing with 
falls data were non-blinded which could be important 
when reporting falls. However, all studies included in 
the primary falls analysis did record falls prospectively 
limiting the risk of recall bias.21 25 26 42 The populations in 
the studies consisted of 82% community-dwelling adults 
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Table 3 Summary of findings table presents the findings and the quality of each outcome using the GRADE considerations
WBV compared with usual care for fracture risk
Bibliography
Outcomes
No of participants
(studies)
Follow-up
Quality of the 
evidence
(GRADE)
Relative effect
(95% CI)
Anticipated absolute effects
Risk with 
usual care Risk difference with WBV
Fractures 710
(1 RCT)
⨁⨁⨁◯
Moderate*
RR 0.48
(0.14 to 1.56)
2 per 100 1 fewer per 100
(2 fewer to 1 more)
Fall rate/person-years 746
(3 RCTs)
⨁⨁⨁◯
Moderate†
Rate ratio 0.67
(0.50 to 0.89)
34 per 100 11 fewer per 100
(17 fewer to 4 fewer)
The risk of experiencing falls 
(fallers)
805
(3 RCTs)
⨁⨁◯◯
Low‡
RR 0.76
(0.48 to 1.20)
23 per 100 6 fewer per 100
(12 fewer to 5 more)
Total bone mineral density 
lumbar spine (BMD spine)
911
(7 RCTs)
⨁⨁⨁◯
Moderate§
– Mean 0
(0 to 0.01 higher)
BMD total hip (BMD hip) 870
(6 RCTs)
⨁⨁◯◯
Low¶
– Mean 0
(0 to 0.01 higher)
Volumetric bone mineral 
density tibia
80
(2 RCTs)
⨁⨁◯◯
Low**
– Mean 0.68 lower
(2.29 lower to 0.93 higher)
Volumetric BMD radius 80
(2 RCTs)
⨁◯◯◯
Very low††
– Mean 1.87 higher
(0.62 lower to 4.36 higher)
Serum biomarker of bone 
resorption (CTX)
138
(2 RCTs)
⨁⨁◯◯
Low**
– Mean 0.01 higher
(−0.06 lower to 0.08 higher)
Serum biomarker of bone 
formation (P1NP)
118
(1 RCT)
⨁⨁◯◯
Low**
– Mean 4.92 higher
(3.06 lower to 12.9 higher)
The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the 
intervention (and its 95% CI).
High quality: We are very confident that the true effect lies close to that of the estimate of the effect; Moderate quality: We are moderately 
confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially 
different; Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the 
effect; Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the 
estimate of effect.
*Serious imprecision, due to the 95% CI around the estimate of effect includes both the possibility of no effect and appreciable benefit.
†Serious study limitations—lack of blinding of the participants reporting falls.
‡Serious study limitations—lack of blinding of the participants reporting fall, and serious imprecision, due to the 95% CI around the pooled 
estimate of effect includes both the possibility of no effect and appreciable benefit.
§Indirectness (surrogate marker for bone strength).
¶Indirectness, and statistical heterogeneity
**Indirectness, and imprecision due to the 95% CI around the estimate of effect includes both the possibility of no effect and appreciable 
benefit.
††indirectness, and imprecision due to the 95% CI around the estimate of effect includes both the possibility of no effect and appreciable 
benefit and statistical heterogeneity.
BMD, bone mineral density; CTX, carboxy-terminal collagen cross-link; GRADE, Working Group grades of evidence; P1NP, propeptide of type 
I collagen; RCTs, randomised controlled trials; RR, risk ratio; WBV, whole-body vibration.
with 90% being female, making the results generalisable 
only to people with similar characteristics.
Strengths of this review include that the evidence is 
obtained from RCTs, followed the PRISMA guidelines of 
reporting and was registered at PROSPERO to improve 
transparency. A thorough literature search was conducted 
with assistance from a research librarian and we further-
more performed a hand search of the reference lists of 
included papers and earlier reviews references.28 29 32–35 
The risk of selection bias was reduced by having two 
independent reviewers select the papers and extract the 
data. In the systematic review, all outcomes were assessed 
regarding quality using the GRADE guidelines where 
fracture is classified as a critical outcome.37 We classi-
fied falls as an important outcome and bone parameters 
being of limited importance as surrogate makers for frac-
ture risk.37 We only pooled homogeneous outcomes in 
the meta-analysis leading to low statistical heterogeneity 
in the falls analysis with moderate statistical heteroge-
neity regarding BMD of the hip and spine. Preassigned 
subgroup analysis for vertical versus side-alternating 
vibration could explain 44.5% of the heterogeneity in 
the lumbar spine analysis, whereas regarding total hip 
BMD, all studies used vertical vibration and no subgroup 
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analysis was performed. Meta-regression analysis was not 
performed due to the insufficient number of studies in 
the analysis.36
comparisons with other studies and reviews
Prior reviews of exercise have shown that exercise 
programme designed to prevent falls in older adults 
also seem to prevent injuries caused by falls, including 
fractures.44 45 The majority of these exercise programme 
included balance training, functional training and 
strengthening exercises. Earlier reviews have shown 
that WBV have balance improving capabilities and the 
ability to improve muscle strength of the lower extrem-
ities,27–31 and WBV might thus prevent fractures by its 
fall-reducing capacity or by lowering the impact of a fall.
Our meta-analysis shows that rate of falls can be 
reduced and suggests a reduction in the proportion of 
fallers. The number needed to treat to prevent one fall 
was 11 (table 3). Sustaining a fall increases the risk of 
injury and reducing the number of times an individual 
falls, even if not the number of fallers may have clinical 
and economic relevance to the individual and to society. 
Falls are very prevalent among the ageing population 
with one in every three adults aged 65+ years old expe-
riencing a fall every year.6 Due to an ageing population, 
a focus on interventions capable of reducing falls seems 
of utmost importance.10 Prior systematic reviews have 
shown that other exercise programmes can reduce fall 
rate through muscle strength and balance training, and 
it has been found that exercising for a period of more 
than 3 hours per week is associated with a larger decrease 
in fall rate.46 WBV exercise consists of shorter workouts 
and with the ability to stand as the only requirement for 
physical function. With the available data the analysis 
shows a fall reduction in the vibration groups with low 
heterogeneity, and with the observational power of the 
post hoc subgroup analyses, we found an association 
between studies with duration longer than 6 months 
and a larger reduction in falls.
To our knowledge, this is the first meta-analysis 
conducted on WBV and falls but earlier findings of a 
positive effect on surrogate markers for falls (balance 
and muscle strength)27–31 can be viewed as an improve-
ment in important risk factors for falls in agreement 
with our findings.
Our results on BMD are consistent with other system-
atic reviews, showing no overall effect on BMD.31–34 
Earlier reviews suggested a positive effect on BMD in 
adolescents32 and in a subgroup analysis with improve-
ments after LWBV on lumbar spine BMD33 and HWBV 
on total hip BMD.32 We found a similar but small effect 
of side alternating vibration on lumbar spine BMD. In 
contrast to others, this systematic review also compre-
hensively assessed other bone parameters, that is, 
bone microarchitecture, turnover markers and BUA. 
We found one study assessing cortical porosity and 
trabecular BMD of tibia and radius20 with no overall 
effect, which is in line with results found in a younger 
age group.47 We found no effect on bone resorption 
markers in line with studies in younger participants.48 49 
One study in this review had a positive effect in bone 
formation markers, but with logarithmic transformed 
data it could not be pooled with non-transformed 
data19 (see online supplementary figure 6). One study 
looked at BUA of the calcaneus showing a positive 
effect39 in conflict with earlier findings from younger 
participants.47 Animal data suggest an effect of WBV on 
bone strength,15–18 but the same effect in humans is not 
evident. Reasons for this include diversities in training 
protocols, duration, adherence, damping of the vibra-
tion by the use of shoes and different standing positions 
on the vibration plates.
In summary, the the evidence from this system-
atic review indicate that WBV may reduce fall rate 
with moderate certainty and the risk of falls with low 
certainty. Future trials could enhance the certainty by 
systematically reporting falls when monitoring adverse 
effects, and if possible by blinding participants. The 
quality of evidence for the effect on bone parameters is 
moderate to low, partly since they are surrogate markers 
of fracture risk, and future research should focus on 
the critical outcome fractures with larger trial sizes and 
adequate follow-up.
cOnclusIOn
In conclusion, our data show a reduced rate of falls by 
WBV. Only one study reported fractures showing a non-sig-
nificant reduction. We found no effect on BMD, and the 
data on microarchitecture and bone turnover markers 
were sparse. WBV exercise could be implemented in 
current falls prevention guidelines. It might potentially 
reduce fractures by reducing falls, but the impact on frac-
tures needs further larger adequately powered studies.
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